Apexigen Obtains $14,990,062 New Financing

  • Feed Type
  • Date
    5/15/2013
  • Company Name
    Apexigen
  • Mailing Address
    863 Mitten Road Burlingame, CA 94010
  • Company Description
    Apexigen is a biopharmaceutical product development company advancing a pipeline of novel product candidates with the potential to address life-threatening and difficult to treat diseases.
  • Website
    http://www.apexigen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,990,062
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.